Senescence as a modulator of oral squamous cell carcinoma development

E Kenneth Parkinson1

  • 1Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London E1 2AD, England, UK. e.k.parkinson@qmul.ac.uk

Oral Oncology
|November 6, 2010
PubMed

Insights

Cellular senescence, a state of permanent cell cycle arrest, can prevent tumor development but may also promote cancer progression in certain contexts, highlighting its complex role in oncology.

Area of Science:

  • Cellular Biology
  • Oncology
  • Molecular Biology

Background:

  • Cellular senescence is a response to various stresses, including telomere shortening and oncogene activation.
  • Senescence involves DNA damage checkpoints, p16(INK4A) overexpression, and cytokine secretion, often observed in pre-malignant lesions.
  • The p16(INK4A) and p53 pathways integrate senescence signals, leading to cell cycle arrest.

Purpose of the Study:

  • To explore the dual role of cellular senescence as both a tumor suppressor and a potential promoter of cancer.
  • To investigate the mechanisms by which senescence influences tumor development and progression.
  • To understand the context-dependent functions of senescence in various cancers, including oral squamous cell carcinoma.

Main Methods:

  • Analysis of cellular senescence markers (e.g., p16(INK4A), p53) in pre-malignant and malignant lesions.
  • Investigation of the impact of senescence in non-epithelial tumor components on epithelial growth and invasion.
  • Review of existing evidence on the interplay between senescence pathways and cancer development.

Main Results:

  • Senescence acts as a barrier to tumor initiation and progression by inducing permanent cell cycle arrest.
  • Dysfunction of pRB/p16(INK4A) and p53 pathways is common in cancers like oral squamous cell carcinoma (OSCC).
  • Senescence in the non-epithelial tumor stroma can paradoxically enhance the growth and invasion of malignant epithelial cells.

Conclusions:

  • Cellular senescence exhibits context-dependent roles in cancer, acting as both a tumor suppressor and a promoter.
  • Understanding the specific mechanisms and tumor microenvironment is crucial for harnessing senescence as a therapeutic strategy.
  • Further research is needed to elucidate the intricate balance between senescence-induced tumor suppression and promotion.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...